Daily Newsletter

04 January 2024

Daily Newsletter

04 January 2024

Nalu raises $65m funding for neurostimulation system expansion

Nalu Medical will use the proceeds from the round to continue product development, and scale operations.

Archana Rani January 04 2024

US-based Nalu Medical has raised $65m in a Series E financing round to further the development and commercialisation of its neurostimulation system for chronic pain treatment.

The funding will primarily accelerate commercial growth and expand clinical and health-economic evidence for the Nalu system, which features the micro-implantable pulse generator (micro-IPG).

The Series E financing round was led by Novo Holdings. It also saw participation from all existing major investors including Aperture Venture Partners, Gilde Healthcare, MVM Partners, and Pura Vida.

Novo Holdings Venture Investments team partner Eric Snyder said: “The differentiated Nalu neurostimulation product has the potential to benefit millions of patients suffering from chronic neuropathic pain.

“We are impressed with their growing body of clinical evidence demonstrating meaningful clinical results in both the emerging market for peripheral nerve stimulation (PNS) and in the established market of spinal cord stimulation (SCS).”

Nalu Medical will also use the proceeds from the round to continue product development and enhance operations.

The company focuses on providing a minimally invasive and non-opioid treatment option for individuals with chronic neuropathic pain.

Nalu Medical president and CEO Tom West said: “The Nalu team is excited about meaningfully expanding and improving the treatment options in the peripheral nerve pain space by setting a new standard of care while also offering a disruptive, minimally invasive, solution in the established spinal cord stimulation market.

“We continue to invest in building clinical data to expand access for patients who often don’t have other therapeutic options.”

In June 2023, Nalu Medical announced the enrolment of the first patient in its COMFORT-2 PNS randomised controlled study for a micro-implantable pulse generator.

Viewing the world’s data by themes makes it simpler to make crucial choices and predictions

GlobalData's latest thematic report will help you to understand and identify the important themes that threaten to disrupt your business in 2024. Our 2024 theme map covers not only disruptive tech themes but also ESG, macroeconomic, and regulatory themes. Reading this report is the first step towards making better business decisions in 2024.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close